Augmentation of cell-mediated cytotoxicity against renal carcinoma cells by recombinant interleukin 2

This publication has 17 references indexed in Scilit:

• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Mechanism of augmentation of natural cytotoxicity by hyman beta-interferon.
  The Keio Journal of Medicine, 1984
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo
  The Journal of Experimental Medicine, 1979
• Cytolytic and proliferative activity of a permanent T killer cell line
  Nature, 1979
• Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
  The Journal of Experimental Medicine, 1978
• Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo
  Nature, 1977
• Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
  Science, 1976
• „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
  European Journal of Immunology, 1975